Zimmer Biomet Holdings, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Zimmer Biomet Holdings, Inc.
Gilead Waives Acquisition Option As Pionyr Explores Other Strategies
Gilead has waived its option to acquire Pionyr, allowing the US biotech to explore other partnerships and financing opportunities as it advances a promising pipeline of macrophage-targeting antibodies.
Medtechs Weigh Up Preferred Growth Strategies As Pandemic Tails Out
Medtech M&A was at a decade low in 2022 and IPOs was a closed market, says EY life sciences partner John Babitt, who gave his thoughts on likely strategic activity in the year ahead to In Vivo.
Globus Medical To Merge With NuVasive In $3.1Bn All-Stock Deal Analysts Foresee Challenges
Analysts from Piper Sandler and BTIG noted that the proposed merger between Globus Medical and NuVasive raises concerns about cultural fit, approach to commercialization and profitability, as well as anti-trust issues.
Minute Insight: Zimmer Biomet Adds Biointegrative Repair Products With Embody Acquisition
Zimmer Biomet reached a definitive agreement to acquire Embody for $155m at closing and up to $120m in future milestones. Embody is a privately held Virginia-based developer of collagen-based bio-fabrication techniques and products for sports medicine applications.
- Medical Devices
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Surgical Sealants
- Other Names / Subsidiaries
- Abbot Spine
- Biomet, Inc.
- Arthrotek, Inc.
- Biomet Biologics, Inc.
- Cayenne Medical, Inc.
- CD Diagnostics
- Clinical Graphics, B.V.
- Dornoch Medical Systems
- Etex corporation
- Implex Corp.
- Knee Creations LLC
- LDR Holding Corporation
- NORMED Medizin-Technik GmbH
- Quantic Biomedical
- Ortho Transmission, LLC
- Zimmer Holdings, Inc.
- A&E Medical Corp.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.